In this episode of the Minding Memory podcast, Ohio State University stroke neurologist Jim Burke discusses the newest FDA-approved drug to treat Alzheimer’s – Lecanemab. Dr. Burke discusses the benefits and drawbacks of the new Alzheimer’s drug and also the paradigm shift of how people (clinicians, patients, and the general population) are thinking about these new Alzheimer’s medications.
